Dolores Catania revealed she gained 20 lbs. after her Mounjaro “stopped working” The RHONJ star she’s “having a really hard ...

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...

Jack Daniel's is losing ground as Americans turn to cannabis, weight-loss drugs, and Gen Z snubs liquor. Discover why whiskey ...

More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in their food and beverage preferences ...

Omada Health, Inc. (NASDAQ:OMDA) closed its first day of trading at $23 per share on Friday, a 21% jump from the IPO price of $19 per share. On Thursday, Omada Health priced its initial public ...

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...

KATIE Price has been cruelly slammed by mum-shaming trolls. The former glamour model, 47, came under fire after she posted a sweet snap with son Harvey, 22, at home It came after Katie shared a ...

Nurse practitioner Shawnda Dorantes says weight-loss drugs are “helping people reclaim their health and confidence like never ...

The increase was driven by rising use of Mounjaro, or tirzepatide, which has been dubbed the “King Kong” of weight loss jabs.

The European Medicines Agency has indicated that Novo Nordisk's drugs, Ozempic and Wegovy, may rarely cause a serious eye ...